Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1853816 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $1.18Day −4.45%Mkt cap $5M1Y −83.3%Off 52W high −83.9%Vol (1Y) 121.8%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,238 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest1.6% of sh out |
| Days to cover1.0d |
| 13F net flow (QoQ)+0.82% |
| Top-10 13F concentration100.0% |
| Next report (est.)2026-08-12 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Earnings (TTM)-$7.1M |
| ROE−194.2% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−49.1% |
| 1Y−83.3% |
| 3Y−99.4% |
| Since incept. (ann.)−84.6% |
Total return through 2026-07-29 · series begins 2021-08-16. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)121.8% |
| Ann. volatility (3Y)129.3% |
| Sharpe (1Y)−0.91 |
| Sharpe (3Y)−0.77 |
| Max drawdown (1Y)−83.9% |
| Max drawdown (3Y)−99.4% |
| Beta (3Y vs SPY)0.89 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 48,334 | $58,483 | 1.20% | new |
| UBS Group AG | 35,608 | $43,085 | 0.89% | +2778.6% |
| Welch & Forbes LLC | 20,000 | $24,200 | 0.50% | new |
| MCF Advisors LLC | 1,732 | $2,096 | 0.04% | new |
| Tower Research Capital LLC (TRC) | 716 | $866 | 0.02% | −64.2% |
| SBI Securities Co., Ltd. | 101 | $122 | 0.00% | +0.0% |
| CITIGROUP INC | 1 | $1 | 0.00% | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-13 | −$0.48 | — | — | — |
| 2025-09-30 | 2025-11-14 | −$1.65 | — | — | — |
| 2025-06-30 | 2025-08-13 | — | — | — | — |
| 2025-03-31 | 2025-05-14 | — | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-12 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
